Conditions: Alzheimer's Disease
Keywords: memantine Alzheimer's Disease communication
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 265
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the effect of memantine versus placebo on functional communication in patients with Alzheimer's Disease

Detailed description:

Arms:
arm 1: Memantine 20mg (10mg twice daily) oral administration for 12 weeks arm 2: Placebo oral administration twice daily for 12 weeks

Interventions: intervention 1: Memantine intervention 2: placebo
Intervention descriptions: intervention 1: Memantine 20mg (10mg twice daily) oral administration for 12 weeks intervention 2: Placebo oral administration twice daily for 12 weeks

Protocol document: